Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BMS-605541

Copy Product Info
🥰Excellent
Catalog No. T26852Cas No. 639858-32-5
Alias BMS605541, BMS 605541

BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).

BMS-605541

BMS-605541

Copy Product Info
🥰Excellent
Purity: 98.71%
Catalog No. T26852Alias BMS605541, BMS 605541Cas No. 639858-32-5
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$31In StockIn Stock
25 mg$66In StockIn Stock
50 mg$107In StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.71%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BMS-605541 AI Summary
BMS-605541 exhibits a diverse range of bioactivities, notably inhibiting human ERG with an IC50 of 16600.0 nM. It demonstrates antiproliferative activity against L2987 cells with an IC50 greater than 2500.0 nM and VEGF-stimulated HUVEC with an IC50 of 25.0 nM. Additionally, BMS-605541 has shown efficacy in inhibiting tumor growth in athymic mice xenografted with HCT116 and L2987 across various doses, demonstrating notable TGI percentages. It also inhibits multiple kinases, including c-kit, PDGFR beta, VEGFR1, FLK1, and VEGFR2, each with distinct IC50 values. Pharmacokinetic properties of BMS-605541 have been characterized in cynomolgus monkey, Sprague-Dawley rat, and Balb/C mouse, covering parameters such as bioavailability, volume of distribution, clearance, half-life, mean residence time, AUC, Tmax, and Cmax..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).
Targets&IC50
PDGFRβ:200 nM, VEGFR1:400 nM, VEGFR2:23 nM, VEGFR2:49 nM (Ki), FLK1:40 nM
SynonymsBMS605541, BMS 605541
Chemical Properties
Molecular Weight401.43
FormulaC19H17F2N5OS
Cas No.639858-32-5
SmilesFc1cc(F)c(cc1NCc1cnc(Nc2ccccn2)s1)C(=O)NC1CC1
Relative Density.1.44 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 36.1 mg/mL (89.93 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.98 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4911 mL12.4555 mL24.9109 mL124.5547 mL
5 mM0.4982 mL2.4911 mL4.9822 mL24.9109 mL
10 mM0.2491 mL1.2455 mL2.4911 mL12.4555 mL
20 mM0.1246 mL0.6228 mL1.2455 mL6.2277 mL
50 mM0.0498 mL0.2491 mL0.4982 mL2.4911 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BMS-605541 | purchase BMS-605541 | BMS-605541 cost | order BMS-605541 | BMS-605541 chemical structure | BMS-605541 formula | BMS-605541 molecular weight